MannKind | MNKD - Ebitda





Ebitda 변화 날짜
Adma Biologics USD 73.59M 14.85M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
MannKind USD 17.92M 8.17M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Novo Nordisk DKK 31.44B 6.84B 2025-09
Pfizer USD 6.08B 351M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Xencor USD -51.05M 55.28M 2025-12